Evidence map›Paper›PMID 41956965›Full record

ReviewChinese medical journal2026

Pathogenesis exploration of lgG4-related disease: From the traditional central dogma and its remodeling perspective.

Shuning Guo, Jing Li, Wen Zhang

Abstract readReview
In one paragraph

Review in Chinese medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shuning GuoDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China.
Jing LiDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China.
Wen ZhangDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100730, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractImmunoglobulin G4-related disease (IgG4-RD) is a chronic disease characterized by inflammation and fibrosis within multiple organs. The fundamental immunopathogenic mechanisms of IgG4-RD remain largely unidentified. Advancements in multiple omics technologies have enabled researchers to characterize the cellular heterogeneity of IgG4-RD. The pursuit of understanding the immune dysfunction in IgG4-RD is principally guided by genomic, transcriptomic, and proteomic investigations, encompassing three crucial aspects of the traditional central dogma. Besides, genetic and epigenetic mechanisms, along with alterations in posttranslational modifications (PTMs) and small molecules identified through metabolomics and microbiomics studies, interact to uncover the functional basis of abnormal cellular activities. Here, we systematically review the application of multiple omics technologies to uncover the fundamental mechanisms driving IgG4-RD, organized around the traditional central dogma of molecular biology and its remodeling. We also propose an integrated pathophysiological model of multi-layered immune dysregulation, illustrating a self-sustaining loop of immune activation and tissue remodeling in IgG4-RD. It is believed that adopting a combination of diverse technological advancements to examine a series of cellular processes holds promise for the development of personalized approaches to managing IgG4-RD patients.

Indexed as

Immunoglobulin GImmunoglobulin G4-Related DiseaseAnimalsHumansProteomicsImmunoglobulin GCentral dogmaEpigeneticsGenomeImmunoglobulin G4-related diseaseMetabolomePosttranscriptional modificationProteomeTranscriptome

Identifiers

PMID41956965
PMCPMC13331411

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.